Bayer’s Nexavar and Xarelto key to future growth

pharmafile | November 9, 2007 | News story | Sales and Marketing Bayer, Xarelto 

Related Content

Bayer and Aignostics to collaborate for AI oncology research

Bayer and Aignostics have announced that they have entered into a strategic collaboration for several …

Bayer’s cardiovascular drug shows impressive Phase III results

Bayer’s finerenone drug has been shown to significantly reduce cardiovascular death or other cardiovascular events …

xarelto_10_tablet1

Bayer’s venous thromboembolism drug Xarelto gets UK approval for children

Bayer has received UK approval for the use of its oral Factor Xa inhibitor Xarelto …

Latest content